BCG Bacillus Calmette Guerin, Tice
activeURL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.4
Version20160713
PublisherOregon Urology StewardDate2016-07-13T01:00:02-04:00Purpose(Clinical Focus: BCG is used for the treatment of non muscle invasive bladder cancer and is administered intravesically),(Data Element Scope: The intent of this data element is to include BCG as a treatment for non muscle invasive bladder cancer),(Inclusion Criteria: Bacillus Calmette Guerin for intravesical use),(Exclusion Criteria: None)
Expansion
| Code | Display | System |
|---|---|---|
| 221050 | http://www.nlm.nih.gov/research/umls/rxnorm |